NLRP3 and neurodegenerative disease: Recent reports suggested that activation of TXNIP/NLRP3 axis was positively associated with pain and emotion disorders and the neuroprotective properties by pharmacological inhibition or genetic deletion of TXNIP following cerebrovascular and neurodegenerative diseases (Nasoohi et al., 2018; Pan et al., 2018).